<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        4-600-18
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PENTHROX 99.9 % liquid for inhalation
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        METHOXYFLURANE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        99.9
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Inhalation use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Inhalation vapour, liquid
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        800.00
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Medical Developments International Limited" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Medical Developments International Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 653]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            YAHMAA MEDICAL COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Medical Developments International Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02BG09
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>PENTHROX contains the active substance methoxyflurane. It is a medicine which is used to reduce pain. It<br />is inhaled through the custom-built PENTHROX Inhaler.<br />PENTHROX is intended to reduce the severity of pain, rather than stop it completely.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use this medicine if you:<br />&bull; are allergic to methoxyflurane, any inhalation anaesthetics or any of the ingredients listed in section 6<br />&bull; have a history or family history of malignant hyperthermia or if you or your family have a history of severe<br />side effects to methoxyflurane. Malignant hyperthermia is a condition where symptoms such as a very<br />high fever, fast, irregular heartbeat, muscle spasms and breathing problems have occurred after you, or a<br />related family member, have been given an anaesthetic<br />&bull; have previously had liver damage after using methoxyflurane or any inhalation anaesthetics<br />&bull; have significant kidney impairment<br />&bull; have a change in the level of consciousness due to any cause including head injury, drugs, or alcohol</p><p>&bull; are suffering from severe circulatory problems<br />&bull; have shallow breathing or difficulty in breathing<br />If you are not sure whether you should be given this medicine, talk to your healthcare professional.<br />Warnings and precautions<br />Talk to your healthcare professional before using this medicine if you:<br />&bull; have liver or kidney problems<br />&bull; have a medical condition which may cause kidney problems<br />&bull; are elderly<br />Other medicines and PENTHROX<br />Tell your healthcare professional if you are taking or have recently taken any other medicines. In particular,<br />tell your healthcare professional if you are taking any of the following:<br />&bull; Isoniazid to treat tuberculosis<br />&bull; Phenobarbital to treat epilepsy<br />&bull; Rifampicin or other antibiotics to treat infection<br />&bull; Medicines, or illegal drugs, that have a dampening effect on the nervous system such as narcotics, pain<br />killers, sedatives, sleeping pills, general anaesthetics, phenothiazines, tranquilisers, muscle relaxants and<br />sedating antihistamines.<br />&bull; Antibiotics and other medicines that may harm the kidney such as tetracycline, gentamicin, colistin,<br />polymyxin B, amphotericin B and contrast agents.<br />Ask your healthcare professional if you are unsure.<br />If you need hospital treatment requiring general anaesthesia, tell the doctors treating you that you have used<br />this medicine.<br />Taking this medicine with food, drink and alcohol<br />Do not drink alcohol whilst taking this medicine as it may increase its effect.<br />You can eat and drink as normal whilst taking this medicine.<br />Pregnancy, breast-feeding and fertility<br />Tell your healthcare professional before taking this medicine if you are pregnant, intending to become<br />pregnant, are breast-feeding or intending to breast-feed. Your healthcare professional will discuss the<br />possible risks and benefits of being given this medicine.<br />Driving and using machines<br />This medicine can affect your ability to drive or use machines safely. Make sure these abilities are not<br />affected before you drive or operate machinery. PENTHROX may cause drowsiness or dizziness in some<br />people.<br />Butylated hydroxytoluene<br />This medicine contains a stabiliser ingredient called butylated hydroxytoluene (E321). Butylated<br />hydroxytoluene may cause local skin reactions (e.g.contact dermatitis), or irritation to the eyes and mucous<br />membranes.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your healthcare professional has told you. Check with your healthcare<br />professional if you are not sure.</p><p>Adults<br />One or two 3 mL bottles of PENTHROX can be used per administration. The maximum dose is two 3mL<br />bottles per administration. Do not inhale more than the maximum dose.<br />How to use PENTHROX<br />1. Your healthcare professional will<br />prepare the PENTHROX Inhaler and<br />place the wrist loop over your wrist.<br />2. Breathe in through the mouthpiece of<br />the inhaler to obtain pain relief. Your<br />healthcare professional will show you<br />how if you are unsure. Accustom<br />yourself to the fruity smell of the<br />medicine by inhaling gently for the first<br />few breaths. Breathe out through the<br />Inhaler. After the first few breaths<br />breathe normally through the inhaler.<br />3. If you need stronger pain relief, cover<br />the dilutor hole on the transparent<br />chamber with charcoal with your finger<br />during use. Your healthcare<br />professional will show you where the<br />hole is.<br />4. You do not need to breathe in and<br />out of the inhaler all of the time. Your<br />healthcare professional will<br />encourage you to take breaks from<br />the inhaler as this will make the pain<br />relief last longer.<br />5. Continue using your inhaler until your<br />healthcare professional tells you to<br />stop, or when you have inhaled the<br />maximum recommended dose.<br />Do not give this medicine to anyone else, even if they have the same condition as you.<br />If you use more PENTHROX than you should</p><p>The healthcare professional giving the PENTHROX will be experienced in its use, so it is extremely unlikely<br />that you will be given too much. You should not use more than 2 bottles at one time. If the maximum dose is<br />exceeded, PENTHROX may cause damage to your kidneys. Tell your healthcare professional immediately if<br />you think you may have taken too much of this medicine.<br />If you have any further questions on the use of this medicine, ask your healthcare professional.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />Common side effects (affects between 1 and 10 people in 100 patients)<br />&bull; Dizziness<br />&bull; Drowsiness<br />&bull; Euphoria<br />&bull; Difficulty in speaking<br />&bull; Memory loss<br />&bull; Anxiety or depression<br />&bull; Taste disturbance, loss of taste or dry mouth<br />&bull; Headache or nausea<br />&bull; Numbness<br />&bull; Low blood pressure<br />&bull; Coughing<br />&bull; Feeling drunk<br />&bull; Sweating<br />Uncommon side effects (affects between 1 and 10 people in 1000 patients)<br />&bull; Tingling or numbness of the hands or feet<br />&bull; Double vision<br />&bull; Mouth discomfort<br />&bull; Tiredness<br />&bull; Feeling abnormal<br />&bull; Increased appetite<br />&bull; Shivering<br />Other side effects (frequency unknown)<br />&bull; Restlessness or agitation<br />&bull; Feeling of being disconnected from reality<br />&bull; Disorientation<br />&bull; Altered state of consciousness<br />&bull; Altered mood<br />&bull; Choking<br />&bull; Shortness of breath<br />&bull; Blood pressure fluctuation<br />&bull; Vomiting<br />&bull; Blurred vision<br />Reporting of side effects<br />If you get any side effects, talk to your healthcare professional. This includes any possible side effects not<br />listed in this leaflet.</p><p>Saudi Arabia:<br />&bull; The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull; Fax: +966-11-205-7662<br />&bull; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-<br />&bull; 2334-2340.<br />&bull; Toll free phone: 8002490000<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: www.sfda.gov.sa/npc<br />Other GCC States:<br />&bull; Please contact the relevant competent authority<br />By reporting side effects, you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Penthrox should be stored below 30&deg;C in its original container.<br />Do not use this medicine after the expiry date. The expiry date refers to the last day of that month.<br />Your healthcare professional will dispose of any leftover PENTHROX liquid and the PENTHROX Inhaler in<br />the appropriate way.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What PENTHROX contains<br />The active substance is Methoxyflurane. Each 3 mL sealed bottle contains 99.9% methoxyflurane.<br />The other ingredient is Butylated hydroxytoluene (E321).<br />What PENTHROX looks like and contents of the pack<br />PENTHROX is a clear, almost colourless volatile liquid, with a characteristic fruity odour that becomes a<br />vapour or gas when used with the PENTHROX Inhaler.<br />PENTHROX is supplied in the following presentations:<br />a) 3 mL bottle with a tear off tamper-evident seal (packs of 10), or<br />b) Combination pack with one 3 mL bottle and one Penthrox Inhaler (packs of 1 or 10), with/without optional<br />activated carbon chamber.<br />Marketing Authorisation Holder and Manufacturer<br />Marketing Authorisation Holder</p><p>Medical Developments International Limited<br />4 Caribbean Drive<br />Scoresby, Victoria 3179<br />Australia<br />mdi@medicaldev.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                The active substance is Methoxyflurane. Each 3 mL sealed bottle contains 99.9% methoxyflurane.
The other ingredient is Butylated hydroxytoluene (E321).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medical Developments International Limited<br />4 Caribbean Drive<br />Scoresby, Victoria 3179<br />Australia<br />mdi@medicaldev.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                08/2016.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي بنثروكس على المادة الفعالة ميثوكسي فلوران. وهو دواء يستخدم لتقليل الألم يتم استنشاقه من خلال جهاز<br />مصمم خصيصا .<br />يهدف بنثروكس إلى تقليل شدة الألم بدلا من إيقافه تماما</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تستخدم هذا الدواء إذا كنت :<br />&bull; لديك حساسية من ميثوكسي فلوران ، أو أي أدوية تخدير عن طريق الاستنشاق أو أي من المكونات المذكورة في القسم 6 .</p><p>قد حدث لك أو لديك تاريخ عائلي من ارتفاع الحرارة الخبيث أو إذا كان لديك أنت أو عائلتك تاريخ مرضي شديد<br />لميثوكسي فلوران. ارتفاع الحرارة الخبيث هو حالة تظهر فيها أعراض مثل ارتفاع شديد في درجة الحرارة وسرعة وعدم<br />انتظام ضربات القلب وتشنجات عضلية ومشاكل في التنفس، قد تظهر معك أو أحد أفراد الأسرة ذوي الصلة ، الذين تم<br />اعطاؤهم مخدرا .<br />&bull; قد سبق و أ ص بت بتلف في الكبد بعد استخدام ميثوكسي فلوران أو استنشاق أي مخدر آخر.<br />&bull; لديك ضعف شديد في الكلى.<br />&bull; حدوث تغيير في مستوى الوعي لأي سبب ، بما في ذلك إصابة الرأس أو المخدرات أو الكحول.<br />&bull; تعاني من مشاكل شديدة في الدورة الدموية.<br />&bull; لديك تنفس ضحل أو صعوبة في التنفس.<br />إذا لم تكن متأكد ا مما إذا كان يجب إعطاؤك هذا الدواء ، فتحدث إلى طبيبك .<br />المحاذير والإحتياطات<br />تحدث إلى طبيبك قبل استخدام هذا الدواء إذا :<br />&bull; لديك مشاكل في الكبد أو الكلى.<br />&bull; لديك حالة طبية قد تسبب مشاكل في الكلى.<br />&bull; كنت من كبار السن<br />الأدوية الأخرى و بنثروكس<br />أخبر طبيبك إذا كنت تتناول أو تناولت مؤخر ا أي أدوية أخرى، وبالأخص، أخبر طبيبك إذا كنت تتناول أي ا مما يلي :<br />&bull; أيزونيازيد لعلاج مرض السل<br />&bull; فينوباربيتال لعلاج الصرع<br />&bull; ريفامبيسين أو المضادات الحيوية الأخرى لعلاج العدوى.<br /> الأدوية أو العقاقير المحظورة التي لها تأثير ملطف على الجهاز العصبي مثل المخدرات ومسكنات الألم والمسكنات<br />والحبوب المنومة والمخدرات العامة وأدوية مجموعة فينوثيازين والمهدئات ومرخيات العضلات ومضادات الهيستامين<br />المهدئة .<br />&bull; المضادات الحيوية والأدوية الأخرى التي قد تضر بالكلى مثل تتراسيكلين و جنتاميسين و كوليستين، بوليميكسين ب ،<br />أمفوتريسين ب وعوامل التباين .<br />اسأل طبيبك إذا كنت غير متأكد .<br />إذا كنت بحاجة إلى علاج في المستشفى يتطلب تخدير ا عام ا ، أخبر الأطباء الذين يعالجونك أنك قد استخدمت هذا الدواء .</p><p>تناول هذا الدواء مع الطعام والشراب والكحول<br />لا تشرب الكحول أثناء تناول هذا الدواء لأنه قد يزيد من تأثيره .<br />يمكنك أن تأكل وتشرب كالمعتاد أثناء تناول هذا الدواء .<br />الحمل والرضاعة والخصوبة<br />أخبري طبيبك قبل تناول هذا الدواء إذا كن ت حاملا ، أو ترغبين بأن تصبحي حاملا أو كن ت مرضعة أو تنوي الإرضاع.<br />سيناقش طبيبك المخاطر والفوائد المحتملة لإعطاء هذا الدواء .<br />القيادة واستعمال الآلات<br />يمكن أن يؤثر هذا الدواء على قدرتك على القيادة أو استخدام الآلات بأمان. تأكد من عدم تأثر هذه القدرات قبل القيادة أو<br />تشغيل الآلات. قد يسبب بنثروكس النعاس أو الدوخة عند البعض.<br />بوتيل هيدروكسي تولوين<br />يحتوي هذا الدواء على عنصر مثبت يسمى بوتيل هيدروكسي تولوين (E321) ، والذي قد يسبب تفاعلات جلدية موضعية<br />)مثل التهاب الجلد التماس ي ( ، أو تهيج في العينين والأغشية المخاطية .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول هذا الدواء دائما تمام ا كما أخبرك طبيبك. تحقق مع طبيبك إذا لم تكن متأكد ا .<br />الكبار<br />يمكن استعمال قارورة أو اثنتين سعة ٣ مل من بنثروكس لكل استخدام. الجرعة القصوى هي قارورتان ٣ مل<br />لكل إستخدام. لا تستنشق أكثر من الجرعة القصوى .<br />كيفية استخدام بنثروكس<br />1 . سيحضر طبيبك جهاز استنشاق بنثروكس ويضع<br />حلقة المعصم على معصمك .<br />2 . تنفس من خلال لسان جهاز الاستنشاق لتسكين الآلام.<br />سيوضح لك طبيبك كيفية ذلك إذا كنت غير متأكد. عو&nbsp;د<br />نفسك على رائحة الفواكه للدواء عن طريق استنشاق أنفاس<br />قليلة بلطف لأول مرة، وأخرج الزفير من خلال جهاز الاستنشاق.<br />بعد استنشاق الأنفاس القليلة الأولى، تنفس بشكل طبيعي من خلال جهاز الاستنشاق .<br />3 . إذا كنت بحاجة إلى تسكين أقوى للألم ، قم بتغطية ثقب المٌخفف على<br />غرفة الفحم الشفافة بإصبعك أثناء الاستخدام. وسيوضح لك طبيبك<br />مكان الثقب.</p><p>4. لا تحتاج للتنفس من جهاز الاستنشاق طوال الوقت. طبيبك<br />سوف يشجعك على أخذ فترات راحة من الاستنشاق لأن<br />هذا سيجعل ازالة الألم تستمر لفترة أطول .<br />5 . استمر في استخدام جهاز الاستنشاق الخاص بك حتى<br />يخبرك طبيبك بالتوقف ، أو عند استنشاق الجرعة القصوى الموصى بها .<br />لا تعط هذا الدواء لأي شخص آخر ، حتى لو كان لديه نفس حالتك .<br />إذا كنت تستخدم بنثروكس أكثر مما ينبغي<br />سيكون طبيبك أو المم رض الذي يعطي بنثروكس من ذوي الخبرة في استخدامه ، لذلك من غير المحتمل للغاية<br />أنك سوف تحصل على الكثير من الجرعات. يجب ألا تستخدم أكثر من قارورتين في وقت واحد. إذا تجاوزت الجرعة<br />القصوى، قد يتسبب بنثروكس في تلف الكلى. أخبر طبيبك أو الممرض على الفور إذا كنت تعتقد أنك قد تناولت الكثير<br />من هذا الدواء .<br />إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء ، اسأل طبيبك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية ، يمكن أن يسبب هذا الدواء آثا را جانبية ، على الرغم من عدم حدوثها لدى الجميع .<br />أعراض جانبية شائعة )تصيب ما بين ١ إلى ١٠ أشخاص من كل ١٠٠ مريض(<br />&bull; دوار<br />&bull; نعاس<br />&bull; نشوة<br />&bull; صعوبة في الكلام<br />&bull; فقدان الذاكرة<br />&bull; القلق أو الاكتئاب<br />&bull; اضطراب حاسة التذوق أو فقدان حاسة التذوق أو جفاف الفم<br />&bull; صداع أو غثيان<br />&bull; الخدر<br />&bull; ضغط دم منخفض<br />&bull; سعال<br />&bull; شعور بحالة ال سكر<br />&bull; تعرَق<br />أعراض جانبية غير شائعة )تؤثر على ما بين ١ إلى ١٠ أشخاص من كل ١٠٠٠ مريض(<br />&bull; وخز أو خدر في اليدين أو القدمين<br />&bull; رؤية مزدوجة</p><p>&bull; ألم الفم<br />&bull; التعب<br />&bull; شعور غير طبيعي<br />&bull; زيادة الشهية<br />&bull; الرجفة<br />أعراض جانبية أخرى (شيوعها غير معروف)<br />&bull; القلق أو الهياج<br />&bull; الشعور بالانفصال عن الواقع<br />&bull; الارتباك<br />&bull; تغيير حالة الوعي<br />&bull; تغير المزاج<br />&bull; الاختناق<br />&bull; ضيق في التنفس<br />&bull; تقلبات ضغط الدم<br />&bull; القيء<br />&bull; عدم وضوح الرؤية<br />التبليغ عن الأعراض الجانبية<br />إذا كنت تعاني من أي آثار جانبية ، فتحدث إلى طبيبك. وهذا يشمل أي آثار جانبية محتملة غير مدرجة في هذه النشرة ،<br />المملكة العربية السعودية:<br />دول مجلس التعاون الخليجي الأخرى:<br />من خلال الإبلاغ عن الآثار الجانبية ، يمكنك المساعدة في توفير مزيد من المعلومات حول سلامة هذا الدواء .<br />المركز الوطني للتيقظ والسلامة الدوائية:<br />- فاكس: +966-11-205 7662<br />- تلفون: +966-11-2038222, exts: 2317-2356-2354-2334-2340<br />- الخط المباشر: 8002490000<br />- البريد الإلكتروني: npc.drug@sfda.gov.sa<br />- الموقع الإلكتروني: www.sfda.gov.sa/npc<br /> يرجى الاتصال بالسلطة المختصة والمعنية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ هذا الدواء بعيدا عن نظر ومتناول الأطفال .<br />يجنبغي تخزين بنثروكس في درجة حرارة أقل من ٣٠ درجة مئوية في عبوته الأصلية .<br />لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من نفس الشهر .<br />سيتخلص طبيبك أو المم رض من أي بقايا لسائل بنثروكس وجهاز الاستنشاق بالطريقة المناسبة .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي ميثوكسي فلوران. تحتوي كل قارورة محكمة الغلق سعة ٣ مل على ٩٩,٩ ٪ ميثوكسي فلوران .<br />المكون الآخر هو بوتيل هيدروكسي تولوين (E321) .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>كيف يبدو بنثروكس وما هي محتويات العبوة<br />بنثروكس سائل متطاير صافٍ ، عديم اللون تقريب ا ، له رائحة فاكهية مميزة تتحول إلى بخار أو غاز عند استخدامه مع<br />جهاز استنشاق بنثروكس .<br />يتوفر بنثروكس في الأشكال التالية :<br />أ) قارورة سعة ٣ مل مع ختم ضد العبث (عبوات من ١٠ ) ، أو<br />ب) عبوة مركبة مع قارورة واحدة سعة ٣ مل وجهاز استنشاق بنثروكس واحد )عبوات من ١ أو ١٠ ( ، مع / بدون<br />غرفة الكربون المنشط الاختيارية .</p><p>للحصول على أي معلومات حول هذا الدواء ، يرجى الاتصال بالممثل المحلي للتسويق:<br />شركة يهماء الطبية<br />69 ساحة الكندي ، الحي الدبلوماسي<br />ص.ب 67864<br />الرياض 11517<br />المملكة العربية السعودية<br />www.yahmaa.com<br />info@yahmaa.com<br />هاتف: +966 11 281 5152<br />تم تحديث هذه النشرة لآخر مرة في أغسطس 2016.<br />مجلس وزراء الصحة العرب<br />اتحاد الصيادلة العرب<br />هذه النشرة تمت الموافقة عليها من هيئة الغذاء والدواء السعودية<br />إن هذا الدواء<br />- الدواء هو منتج يؤثر على صحتك واستهلاكه خلافا للتعليمات أمر خطير بالنسبة لك.<br />- اتبع وصفة الطبيب، وطريقة الاستخدام وتعليمات الصيدلي الذي باع الدواء.<br />- الطبيب والصيدلي هم الخبراء في مجال الأدوية وفوائدها ومخاطرها.<br />- لا تقم من تلقاء نفسك بوقف فترة العلاج المقررة لك.<br />- لا تكرر نفس الوصفة الطبية دون استشارة الطبيب.<br />- تحفظ جميع الأدوية بعيدا عن متناول الأطفال</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة ميديكال دفيلوبمنتز انترناشيونال المحدودة<br />4 كاريبيان درايف<br />سكورسبي ، فيكتوريا 3179 ، أستراليا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            08/2016.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                PENTHROX 3 mL inhalation vapour, liquid
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each vial contains 3 mL of methoxyflurane 99.9%.
For full list of excipients see, section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Inhalation vapour, liquid.
Clear, almost colourless, volatile liquid, with a characteristic fruity odour.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Inhalation vapour, liquid.<br />Clear, almost colourless, volatile liquid, with a characteristic fruity odour.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PENTHROX should be self-administered under supervision of a person trained in its<br />administration, using the hand held PENTHROX Inhaler.<br />One bottle of 3 mL PENTHROX to be vaporised in a PENTHROX inhaler. On<br />finishing the 3 mL dose, another 3 mL may be used. Dose of PENTHROX should not<br />exceed 6 mL in a single administration. Methoxyflurane may cause renal failure if the<br />recommended dose is exceeded. The lowest effective dosage of PENTHROX to<br />provide analgesia should be used.<br />Onset of pain relief is rapid and occurs after 6 &ndash; 10 inhalations. Patients should be<br />instructed to inhale intermittently to achieve adequate analgesia. Patients are able to<br />assess their own level of pain and titrate the amount of PENTHROX inhaled for<br />adequate pain control. Continuous inhalation provides analgesic relief for up to 25-<br />30 minutes. Intermittent inhalation may provide longer analgesic relief. Patients should<br />be advised to take the lowest possible dose to achieve pain relief.<br />The frequency at which PENTHROX can be safely used is not established.<br />Administration on consecutive days is not recommended and the total dose to a patient<br />in a week should not exceed 15 mL (see section 4.4).<br />Method of Administration<br />Instructions on the preparation of the PENTHROX Inhaler and correct administration<br />are provided in the Figures below.</p><p>1<br />Ensure the Activated Carbon (AC) Chamber is<br />inserted into the dilutor hole on the top of the<br />PENTHROX Inhaler.<br />2<br />Remove the cap of the bottle by hand.<br />Alternatively, use the base of the PENTHROX<br />Inhaler to loosen the cap with a &frac12; turn. Separate<br />the Inhaler from the bottle and remove the cap by<br />hand.<br />3<br />Tilt the PENTHROX Inhaler to a 45&deg; angle and<br />pour the total contents of one PENTHROX bottle<br />into the base of the Inhaler whilst rotating.<br />4<br />Place wrist loop over patient&rsquo;s wrist. Patient<br />inhales through the mouthpiece of the<br />PENTHROX Inhaler to obtain analgesia. First<br />few breaths should be gentle and then breathe<br />normally through Inhaler.<br />5<br />Patient exhales into the PENTHROX Inhaler.<br />The exhaled vapour passes through the AC<br />Chamber to adsorb any exhaled methoxyflurane.<br />6<br />If stronger analgesia is required, patient can<br />cover dilutor hole on the AC chamber with finger<br />during use.</p><p>7<br />Patient should be instructed to inhale<br />intermittently to achieve adequate analgesia.<br />Continuous inhalation will reduce duration of<br />use. Minimum dose to achieve analgesia should<br />be administered.<br />8<br />Replace cap onto PENTHROX bottle. Place used<br />PENTHROX Inhaler and used bottle in sealed plastic<br />bag and dispose of responsibly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Use as an anaesthetic agent.
Hypersensitivity to PENTHROX or any fluorinated anaesthetic.
Malignant hyperthermia: patients with known or genetically susceptible to malignant
hyperthermia or a history of severe adverse reactions in either patient or relatives.
Patients who have a history of showing signs of liver damage after previous
methoxyflurane use or halogenated hydrocarbon anaesthesia.
Clinically significant renal impairment.
Altered level of consciousness due to any cause including head injury, drugs, or
alcohol.
Clinically evident cardiovascular instability.
Clinically evident respiratory depression.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Renal disease<br />Methoxyflurane causes significant nephrotoxicity at high doses. Nephrotoxicity is also<br />related to the rate of metabolism. Therefore factors that increase the rate of metabolism<br />such as drugs that induce hepatic enzymes can increase the risk of toxicity with<br />methoxyflurane as well as sub-groups of people with genetic variations that may result<br />in fast metaboliser status (see section 4.5). Nephrotoxicity is thought to be associatedwith inorganic fluoride ions, a metabolic break-down product. Toxicity in the past<br />when used as an anaesthetic agent has been determined to be associated with serum<br />levels greater than 40 &mu;mol/L. Following a single dose of 3 mL serum levels did not<br />exceed 10 &mu;mol/L.<br />Despite this safety margin the lowest effective dose of methoxyflurane should be<br />administered, especially in the elderly or patients with other known risk factors of renal<br />disease. In addition, methoxyflurane should be cautiously used in patients diagnosed<br />with clinical conditions that would pre-dispose to renal injury.<br />Liver disease<br />Methoxyflurane is metabolised in the liver, therefore increased exposures in patients<br />with hepatic impairment can cause toxicity. PENTHROX must not be used in patients<br />who have a history of showing signs of liver damage after previous methoxyflurane use<br />or halogenated hydrocarbon anaesthesia. PENTHROX should be used with care in<br />patients with underlying hepatic conditions or with risks for hepatic dysfunction (such<br />as enzyme inducers - see also section 4.5).<br />It has been reported that previous exposure to halogenated hydrocarbon anaesthetics<br />(including methoxyflurane when used in the past as an anaesthetic agent), especially if<br />the interval is less than 3 months, may increase the potential for hepatic injury.<br />Cautious clinical judgement should be exercised when PENTHROX is to be used more<br />frequently than on one occasion every 3 months.<br />Cardiovascular system depression / Use in elderly<br />Potential effects on blood pressure and heart rate are known class-effects of high dose<br />methoxyflurane used in anaesthesia and other anaesthetics. They do not appear to be<br />significant at the analgesic doses. There is no particular pattern to the patients&rsquo; systolic<br />BP levels after methoxyflurane administration as an analgesic across age groups.<br />However, as the risk may potentially be increased for older people with hypotension<br />and bradycardia, caution should be exercised in the elderly due to possible reduction in<br />blood pressure.<br />Central nervous system effects<br />Secondary pharmacodynamic effects including potential CNS effects such as sedation,<br />euphoria, amnesia, ability to concentrate, altered sensorimotor co-ordination andchange in mood are also known class-effects. Self-administration of methoxyflurane in<br />analgesic doses will be limited by occurrence of CNS effects, such as sedation.<br />Additionally, the CNS effects can be a risk factor for potential abuse.<br />Occupational exposure<br />Healthcare professionals who are regularly exposed to patients using PENTHROX<br />inhalers should be aware of any relevant occupational health and safety guidelines for<br />the use of inhalational agents. To reduce occupational exposure to methoxyflurane, the<br />PENTHROX Inhaler should always be used with the Activated Carbon (AC) Chamber<br />which adsorbs exhaled methoxyflurane. Multiple use of PENTHROX Inhaler without<br />the AC Chamber creates additional risk. Elevation of liver enzymes, blood urea<br />nitrogen and serum uric acid have been reported in exposed maternity ward staff in<br />delivery wards when methoxyflurane was used in the past in obstetric patients at the<br />time of labour and delivery.<br />Frequent repeated use<br />Due to the limitations on the dose of PENTHROX (maximum - 6ml) and the duration<br />of pain relief, PENTHROX is not appropriate for providing relief of break-through<br />pain/exacerbations in chronic pain conditions. PENTHROX is also not appropriate for<br />relief of trauma related pain in closely repeated episodes for the same patient.<br />Butylated hydroxytoluene<br />PENTHROX contains the excipient, butylated hydroxytoluene (E321), a stabiliser.<br />Butylated hydroxytoluene may cause local skin reactions (e.g. contact dermatitis), or<br />irritation to the eyes and mucous membranes. See section 6.1.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The metabolism of methoxyflurane is mediated by the CYP 450 enzymes particularly<br />CYP 2E1 and to some extent CYP 2A6. It is possible that enzyme inducers (such as<br />alcohol or isoniazid for CYP 2E1 and phenobarbital or rifampicin for CYP 2A6)<br />which increase the rate of methoxyflurane metabolism might increase its potential<br />toxicity and they should be avoided concomitantly with methoxyflurane.<br />Concomitant use of PENTHROX with CNS depressants, such as opioids, sedatives or<br />hypnotics, general anaesthetics, phenothiazines, tranquillisers, skeletal muscle<br />relaxants, sedating antihistamines and alcohol may produce additive depressant<br />effects. If opioids are given concomitantly with PENTHROX, the patient should be<br />observed closely, as is normal clinical practice with opioids.<br />Concomitant use of methoxyflurane with medicines (e.g. contrast agents and some<br />antibiotics) which are known to have a nephrotoxic effect should be avoided as there<br />may be an additive effect on nephrotoxicity. Antibiotics with known nephrotoxic<br />potential include tetracycline, gentamicin, colistin, polymyxin B and amphotericin B.<br />It is advisable to avoid using sevoflurane anaesthesia following methoxyflurane<br />analgesia, as sevoflurane increases serum fluoride levels and nephrotoxicity of<br />methoxyflurane is associated with raised serum fluoride.<br />There are no reported drug interactions when used at the analgesic dosage (3 &ndash; 6 mL).</p><p>When methoxyflurane was used for anaesthesia at the higher doses of 40 &ndash; 60 mL,<br />there were reports of:<br />a) Drug interaction with hepatic enzyme inducers (e.g. barbiturates) increasing<br />metabolism of methoxyflurane and resulting in a few reported cases of<br />nephrotoxicity. There is insufficient information to show whether enzyme<br />induction affects liver damage after an analgesic dose of methoxyflurane.<br />b) Reduction of renal blood flow and hence anticipated enhanced renal effect when<br />used in combination with drugs (e.g. barbiturates) reducing cardiac output.<br />c) Class effect on cardiac depression which may be enhanced by other cardiac<br />depressant drugs, e.g. intravenous practolol during cardiac surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fertility<br />No clinical data on effects of methoxyflurane on fertility are available. Limited data<br />from animal studies do no indicate any effects on sperm morphology.<br />Pregnancy<br />Animal studies do not indicate direct or indirect harmful effects with respect to<br />reproductive toxicity (see section 5.3).<br />Where methoxyflurane has been used for obstetric analgesia in pregnant women, there<br />has been a single report of neonatal respiratory depression associated with a high fetal<br />level of methoxyflurane. However, when low concentrations were administered, or the<br />duration of higher concentrations was kept short, per recommended posology,<br />methoxyflurane was found to have little effect on the fetus. No fetal complications were<br />reported to result from methoxyflurane analgesia in the mother in all the studies<br />completed in obstetric analgesia.<br />As with all medicines care should be exercised when administered during pregnancy<br />especially the first trimester.<br />Breast-feeding<br />There is insufficient information on the excretion of methoxyflurane in human milk.<br />Caution should be exercised when methoxyflurane is administered to a nursing mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Methoxyflurane may have a minor influence on the ability to drive and use machines.<br />Dizziness, somnolence and drowsiness may occur following the administration of<br />methoxyflurane (see section 4.8). Patients should be advised not to drive or operate<br />machinery if they are feeling drowsy or dizzy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of safety profile<br />The most common non-serious reactions are CNS type reactions such as dizziness, and<br />somnolence (&ge;1/100 to &lt;1/10), and are generally easily reversible.<br />Serious dose-related nephrotoxicity has only been associated with methoxyflurane<br />when used in large doses over prolonged periods during general anaesthesia.</p><p>Methoxyflurane is therefore no longer used for anaesthesia. See section 4.4 under renal<br />disease. The recommended maximum dose for PENTHROX should therefore not be<br />exceeded.<br />Tabulated list of adverse reactions<br />The adverse drug reactions observed in PENTHROX clinical studies in analgesia are<br />listed in the table below, classified according to frequency (common &ge;1/100 to &lt;1/10;<br />uncommon &ge;1/1,000 to &lt;1/100).</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:163px">MedDRA System Organ Class</td><td style="width:179px">Common<br />&ge;1/100 to &lt;1/10</td><td style="width:157px">Uncommon<br />&ge;1/1,000 to &lt;1/100</td></tr><tr><td style="width:163px">Nervous system disorders</td><td style="width:179px">Amnesia<br />Anxiety<br />Depression<br />Dizziness<br />Dysarthria<br />Dysgeusia<br />Euphoria<br />Headache<br />Sensory neuropathy<br />Somnolence</td><td style="width:157px">Paraesthesia</td></tr><tr><td style="width:163px">Cardiac disorders</td><td style="width:179px">Hypotension</td><td style="width:157px">&nbsp;</td></tr><tr><td style="width:163px">Eye disorders</td><td style="width:179px">&nbsp;</td><td style="width:157px">Diplopia</td></tr><tr><td style="width:163px">Respiratory, thoracic and<br />mediastinal disorders</td><td style="width:179px">Coughing</td><td style="width:157px">&nbsp;</td></tr><tr><td style="width:163px">Gastrointestinal disorders</td><td style="width:179px">Dry mouth<br />Nausea</td><td style="width:157px">Oral discomfort</td></tr><tr><td style="width:163px">General disorders</td><td style="width:179px">Feeling drunk</td><td style="width:157px">Fatigue<br />Feeling abnormal<br />Increased appetite<br />Shivering</td></tr><tr><td style="width:163px">Skin and subcutaneous tissue disorders</td><td style="width:179px">Sweating</td><td style="width:157px">&nbsp;</td></tr></tbody></table><p>Post-marketing experience<br />Rare (&ge;1/10,000 to &lt;1/1,000) reports of hepatic failure/hepatitis have been observed<br />with analgesic use of methoxyflurane.<br />Other events linked to the methoxyflurane use in analgesia (in addition to the reactions<br />from clinical trials listed above), including reports from the literature include:<br />- Nervous system disorders: drowsiness, agitation, restlessness, dissociation, affect<br />lability, disorientation, altered state of consciousness<br />- Respiratory system: choking, hypoxia, oxygen saturation decreased<br />- Cardiovascular system: blood pressure fluctuation<br />- Gastrointestinal: vomiting</p><p>- Hepatic: hepatitis, increased liver enzymes, jaundice, liver injury<br />- Renal: increased serum uric acid, urea nitrogen and creatinine, renal failure<br />- Eyes: blurred vision, nystagmus<br />To reports any side effect(s):<br />Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />Other GCC States:<br />Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should be observed for signs of drowsiness, pallor and muscle relaxation<br />following methoxyflurane administration.<br />High doses of methoxyflurane cause dose related nephrotoxicity. High output renal<br />failure has occurred several hours or days after the administration of repeated high<br />analgesic or anaesthetic doses of methoxyflurane.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacodynamic effects<br />Methoxyflurane vapour provides analgesia when inhaled at low concentrations. After<br />methoxyflurane administration, drowsiness may occur. During methoxyflurane<br />administration, the cardiac rhythm is usually regular. The myocardium is only<br />minimally sensitised to adrenaline by methoxyflurane. At analgesic therapeutic doses<br />pain relief may lead to some decrease in blood pressure. This may be accompanied by<br />bradycardia.<br />Clinical efficacy and safety<br />The efficacy and safety of PENTHROX was demonstrated in MEOF-001, a<br />randomised, double-blind, multi-centre, placebo controlled study in the treatment of<br />acute pain in patients with minor trauma presenting to an Emergency Department.<br />300 patients were recruited (149 received methoxyflurane and 149 received placebo in<br />a 1:1 ratio). Patients with a pain score of &ge; 4 to &le; 7 on the Numerical Rating Scale were<br />eligible for the study. The mean pain scores (Visual Analogue Scale) observed at<br />baseline were similar in the methoxyflurane (64.8) and placebo (64.0) groups. The<br />primary efficacy variable, the estimated mean change in VAS pain from Baseline<br />to 5 min, 10 min, 15 min and 20 min, was greater for the methoxyflurane group (-<br />23.1, -28.9, -34.0 and -35.0 respectively) when compared to the placebo group (-<br />11.3, -14.8, -15.5 and -19.0 respectively). Overall, there was a highly significant<br />difference between the methoxyflurane and placebo group (estimated treatment<br />effect -15.1; 95% CI -19.2 to -11.0; p&lt;0.0001). The greatest treatment effect was<br />seen at 15 minutes (estimated treatment effect of -18.5). An analysis was<br />undertaken where a responder was defined as a patient who experienced at least a<br />30% improvement from baseline VAS pain score. Results of this analysis indicated<br />that percentage of responders at 5, 10, 15 and 20 mins was significantly greater for<br />the methoxyflurane group (51.0%, 57.7%, 63.8%, 63.8%) when compared to the<br />placebo group (23.5%, 30.9%, 33.6%, 37.6%), with p &lt; 0.0001 at each time-point.<br />A total of 126 patients (84.6%) in the methoxyflurane group experienced their first<br />pain relief after 1-10 inhalations in comparison to 76 patients (51%) in the placebo<br />group.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Methoxyflurane has the following partition coefficients:<br />&bull; a water/gas coefficient of 4.5,<br />&bull; a blood/gas coefficient of 13 and<br />&bull; an oil/gas coefficient of 825<br />Methoxyflurane enters the lungs in the form of a vapour and is rapidly transported<br />into the blood, therefore there is a rapid onset of analgesic action.</p><p>Distribution<br />Methoxyflurane has a high oil/gas coefficient hence methoxyflurane is highly<br />lipophilic. Methoxyflurane has great propensity to diffuse into fatty tissues where it<br />forms a reservoir from which it is released slowly over days.<br />Metabolism<br />Biotransformation of methoxyflurane occurs in man. Methoxyflurane is metabolised<br />by dechlorination and o-demethylation in the liver, mediated by CYP 450 enzymes<br />particularly CYP 2E1 and CYP 2A6. Methoxyflurane is metabolised to free fluoride,<br />oxalic acid, difluoromethoxyacetic acid, and dichloroacetic acid. Both free fluoride and<br />oxalic acid can cause renal damage at concentrations higher than those achievable with<br />single analgesic dose use. Methoxyflurane is more susceptible to metabolism than other<br />halogenated methyl ethyl ethers and has greater propensity to diffuse into fatty tissues.<br />Hence methoxyflurane is released slowly from this reservoir and becomes available for<br />biotransformation for many days.<br />Excretion<br />Approximately 60% of methoxyflurane uptake is excreted in the urine as organic<br />fluorine, fluoride and oxalic acid; the remainder is exhaled unaltered or as carbon<br />dioxide. Higher peak blood fluoride levels may be obtained earlier in obese than in nonobese<br />people, and in the elderly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Embryo-fetal development<br />In studies in mice and rats, methoxyflurane crossed the placenta but demonstrated no<br />evidence of embryotoxic or teratogenic properties. However, delayed fetal<br />development (reduced fetal body weight and decreased ossification) was observed<br />following repeated dosing over 9 days. The no observed adverse effect level (NOAEL)<br />for embryo-fetal development was 0.006% - 4h/day in mice and close to 0.01% - 8<br />h/day in rats. The NOAELs in mouse and rat represent a 1- to 2-fold margin on a mg/kg<br />basis and a 0.1- to 0.3-fold margin on a mg/m2 basis versus the proposed maximum<br />clinical dose. As PENTHROX is not intended for daily use, the risk of delayed fetal<br />development is considered to be very low.<br />Hepatic effects<br />Repeated intermittent or continuous administration of subanaesthetic concentrations of<br />methoxyflurane has been associated with limited and commonly reversible hepatic<br />changes (fatty metamorphosis, elevated ALT/AST) in several species. A NOAEL has<br />not been established. These effects were seen at exposures considered sufficiently in<br />excess of those anticipated through normal clinical use of the product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Butylated hydroxytoluene E321 (stabiliser).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PENTHROX is supplied in the following presentations:<br />3 mL bottle with a tear off tamper-evident seal (packs of 10)<br />Combination pack with one 3 mL bottle, one PENTHROX Inhaler and one Activated<br />Carbon (AC) chamber (packs of 1).<br />Combination pack with one 3 mL bottle and one PENTHROX Inhaler (packs of 10)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After loading the PENTHROX Inhaler, replace cap onto PENTHROX bottle. After<br />use, place used PENTHROX Inhaler and used bottle in plastic bag provided, seal and<br />dispose of responsibly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medical Developments International Limited
4 Caribbean Drive
Scoresby, Victoria 3179
Australia
mdi@medicaldev.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                August 2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>